In its fourth consecutive year, the Women and HIV Think Tank officially changed its name to the "Women's Research Initiative on HIV/AIDS (WRI)" in 2005 to accurately reflect the real work of this group, to convey our ongoing commitment to tangible and measurable results in the management of HIV disease in women, and to establish TWP's role in providing sustained leadership for this effort. The most significant outcome of the 2005 meeting is the unequivocal consensus that emerged that increasing the participation of women in research is the most tangible mechanism for improving HIV treatment and prevention efforts for all women over the long term. Participants elected to form three working groups to pursue initiatives in 2006:
- Standards of Treatment and Care
- Policy Agenda
- Community Engagement
The 2005 Think Tank included thirty of the nearly sixty individuals involved in this initiative. Following our multidisciplinary focus, the participants represented research institutions, clinics, government agencies, advocacy organizations, and pharmaceutical companies. A list of the 2005 meeting participants can be found below.
For the full 2005 meeting report and a detailed action plan of the working groups, please click below.
2005 WRI Meeting Participants
Judith D. Auerbach, PhD
Vice President, Public Policy and Program Development
amfAR
Dawn Averitt Bridge
Founder
The Well Project
Gina Brown, MD
Medical Director
Cicatelli Associates, Inc.
Susan Ellen Cohn, MD, MPH
Associate Professor of Medicine
University of Rochester
Jenna Conley
Senior Manager
Gilead Sciences
Robert W. Coombs, MD, PhD, FRCPC
Professor, Laboratory Medicine
University of Washington
Terri Creagh, PhD
Clinical and Epidemiologic Research
Ron Falcon, MD
Medical Director, Virology
Tibotec Therapeutics
Judith Feinberg, MD
Professor of Medicine
University of Cincinnati
Becky Griesse
Research Assistant
Forum for Collaborative HIV Research
Jane Hitti, MD
University of Washington Medical Center
Beri Hull
Global Advocacy Officer: Access to Care, Treatment and Support
The International Community of Women Living with HIV and AIDS (ICW)
Ben Kozub
Product Manager, HIV
Boehringer Ingelheim Pharmaceuticals
Sharon Lee, MD
Director
Family Health Center
Heidi Nass
Coordinator, Treatment Support and Education Program
HIV Care Program, University of Wisconsin Hospital and Clinics
Nancy Norman, MD, MPH
Medical Director
Boston Public Health Commission
Cathy Olufs
Education Director
CorrectHELP - The Corrections HIV Education and Law Project
Nancy Padian, PhD
Professor
UCSF
Andrew Pavia, MD
University of Utah
Kristy D. Porter, PharmD
Associate Director, Virology Medical Affairs
Bristol-Myers Squibb
Tonia Poteat, PA-C
Grady Infectious Disease Program
Patricia Reichelderfer, PhD
Microbiologist
NIH/NICHD
Star Seyedkazemi, PharmD
Clinical Science Manager, Abbott Virology
Abbott Laboratories
Kathleen E. Squires, MD
Director, Division of Infectious Diseases
Thomas Jefferson University
Stephen Storfer, MD
Associate Director, Virology
Clinical and Scientific Affairs
Boehringer Ingelheim Pharmaceuticals, Inc.
Melanie Thompson, MD
Principal Investigator
AIDS Research Consortium of Atlanta
Fulvia Veronese, PhD
Health Science Administrator
NIH, Office of AIDS Research
Etiology and Pathogenesis and Microbicide Section
Meeting Staff
Megan Raspa
Project Manager
The Well Project
Facilitators
Richard Averitt
Chief Operating Officer
The Well Project
Ron Wilder
President
Aligned Action, Inc.
Meeting Planners
Debbie Cooke
VP, Chief Operations Officer
Meeting Masters, Inc.
Tina DeRenzis
President
Meeting Masters, Inc.
